etoposide: Definition from Answers.com
It may also be referred to as VP-16, VP-16-213, and epipodophyllotoxin.
Etopophos is a different formulation of the intravenous form of etoposide. ...
www.answers.com/topic/etoposide

VP-16-213 - definition of VP-16-213 in the Medical dictionary - by ...
etoposide /eto·po·side/ (e″to-po´sīd) a semisynthetic derivative of
podophyllotoxin used as the base or the phosphate salt as an antineoplastic, ...
medical-dictionary.thefreedictionary.com/VP-16-213

National Cancer Institute: Information from Answers.com
... L-Asparaginase (Elspar) (1978); Daunomycin (Cerubidine) (1979); VP-16-213 (
Etoposide) (1983); VM-26 (Teniposide) (1992); Taxol (Paclitaxel) (1992) ...
www.answers.com/topic/national-cancer-institute

Etoposide (VP-16-213)-induced gene alterations: potential ...
A semisynthetic derivative of podophyllotoxin, etoposide is also called Vepesid
(Bristol; code designation VP-16-213, abbreviated VP-16). ...
www.pnas.org/content/88/19/8740.abstract

Determination of etoposide (VP16-213) and teniposide (VM-26) in ...
1, O. 125128, 1984 (G) 1984 Pergamon Press Ltd. Printed in Great Britain Short
Communication Determination of etoposide (VP16213) and teniposide (VM26) in ...
linkinghub.elsevier.com/retrieve/pii/0731708584800989

Blood -- Preclinical assessment of purging with VP-16-213: key ...
Preclinical assessment of purging with VP-16-213: key role for long- term marrow
cultures. BH Kushner, JH Kwon, SC Gulati and H Castro-Malaspina ...
www.bloodjournal.org/cgi/content/abstract/69/1/65

IngentaConnect Absorption of Etoposide VP-16-213 from the Small ...
The absorption of etoposide (VP-16-213) was investigated in a perfused
intestinal loop. The absorbed amount of drug was determined by collecting the
blood ...
www.ingentaconnect.com/content/klu/ pham/1985/00000002/00000004/00307165

High-dose VP-16-213 monotherapy for refractory germinal ...
VP-16-213 at standard dose is one of the more active agents for the treatment of
germ cell tumors. In previous phase I studies, VP-16-213 has been ...
www.jco.org/cgi/content/abstract/2/4/271

Blood -- Aclacinomycin A and etoposide (VP-16-213): an effective ...
Thirty-five patients with acute myelogenous leukemia were treated with
aclacinomycin A (60 mg/m2/day for 5 days) and VP-16-213 (100 mg/m2/day for 5
days). ...
www.bloodjournal.org/cgi/content/abstract/71/4/992

Epipodophyllotoxin (VP16-213) in small cell carcinoma of the ...
In 38 consecutive patients VP16-213 was used as the sole treatment for relapse
or for failure ... All 38 patients starting VP16-213 were ambulant and judged
...
www.springerlink.com/index/K7176NT8637Q2MT1.pdf